{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:58:58Z","timestamp":1794866338216,"version":"4.9.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["K23DK125838"],"award-info":[{"award-number":["K23DK125838"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32CA009001"],"award-info":[{"award-number":["T32CA009001"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35CA253185"],"award-info":[{"award-number":["R35CA253185"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R24DK110499"],"award-info":[{"award-number":["R24DK110499"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009560","name":"American Gastroenterological Association","doi-asserted-by":"publisher","award":["Research Scholars Award"],"award-info":[{"award-number":["Research Scholars Award"]}],"id":[{"id":"10.13039\/100009560","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011684","name":"Crohn's and Colitis Foundation","doi-asserted-by":"publisher","award":["Career Development Award"],"award-info":[{"award-number":["Career Development Award"]}],"id":[{"id":"10.13039\/100011684","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Massachusetts General Hospital\/Chen Institute Transformative Scholar in Medicine","id":[{"id":"https:\/\/ror.org\/002pd6e78","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["Research Professorship"],"award-info":[{"award-number":["Research Professorship"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-025-01318-6","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T05:04:24Z","timestamp":1751432664000},"page":"1476-1492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Multi-omic analysis reveals transkingdom gut dysbiosis in metabolic dysfunction-associated steatotic liver disease"],"prefix":"10.1038","volume":"7","author":[{"given":"Hanseul","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Nzabarushimana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4929-8955","authenticated-orcid":false,"given":"Jiaxian","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrisha","family":"Bhosle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8593-0762","authenticated-orcid":false,"given":"Brittany","family":"Berdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giana","family":"Frongillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Livny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8233-6274","authenticated-orcid":false,"given":"Frank B.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey G.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"McIver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Franzosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7284-6767","authenticated-orcid":false,"given":"Andrew T.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Hayete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey N.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1110-0096","authenticated-orcid":false,"given":"Curtis","family":"Huttenhower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5436-4219","authenticated-orcid":false,"given":"Long H.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"1318_CR1","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol. 79, 1542\u20131556 (2023).","journal-title":"J. Hepatol."},{"key":"1318_CR2","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes, C., Razavi, H., Loomba, R., Younossi, Z. & Sanyal, A. J. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 67, 123\u2013133 (2018).","journal-title":"Hepatology"},{"key":"1318_CR3","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nrgastro.2017.72","volume":"14","author":"L-X Yu","year":"2017","unstructured":"Yu, L.-X. & Schwabe, R. F. The gut microbiome and liver cancer: mechanisms and clinical translation. Nat. Rev. Gastroenterol. Hepatol. 14, 527\u2013539 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1318_CR4","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams, L. A., Anstee, Q. M., Tilg, H. & Targher, G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut 66, 1138\u20131153 (2017).","journal-title":"Gut"},{"key":"1318_CR5","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","volume":"70","author":"TG Simon","year":"2021","unstructured":"Simon, T. G., Roelstraete, B., Khalili, H., Hagstr\u00f6m, H. & Ludvigsson, J. F. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. Gut 70, 1375\u20131382 (2021).","journal-title":"Gut"},{"key":"1318_CR6","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/cld.716","volume":"11","author":"E Cleveland","year":"2018","unstructured":"Cleveland, E., Bandy, A. & VanWagner, L. B. Diagnostic challenges of nonalcoholic fatty liver disease\/nonalcoholic steatohepatitis. Clin. Liver Dis. 11, 98\u2013104 (2018).","journal-title":"Clin. Liver Dis."},{"key":"1318_CR7","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41576-022-00529-x","volume":"24","author":"H VanEvery","year":"2023","unstructured":"VanEvery, H., Franzosa, E. A., Nguyen, L. H. & Huttenhower, C. et al. Microbiome epidemiology and association studies in human health. Nat. Rev. Genet. 24, 109\u2013124 (2023).","journal-title":"Nat. Rev. Genet."},{"key":"1318_CR8","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1499-3872(17)60019-5","volume":"16","author":"F Shen","year":"2017","unstructured":"Shen, F. et al. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease. Hepatobil. Pancreat. Dis. Int. 16, 375\u2013381 (2017).","journal-title":"Hepatobil. Pancreat. Dis. Int"},{"key":"1318_CR9","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/hep.26319","volume":"58","author":"M Mouzaki","year":"2013","unstructured":"Mouzaki, M. et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology 58, 120\u2013127 (2013).","journal-title":"Hepatology"},{"key":"1318_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/hep.28697","volume":"65","author":"JC-F Leung","year":"2017","unstructured":"Leung, J. C.-F. et al. Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients. Hepatology 65, 54\u201364 (2017).","journal-title":"Hepatology"},{"key":"1318_CR11","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","volume":"5","author":"Q Ye","year":"2020","unstructured":"Ye, Q. et al. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 5, 739\u2013752 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1318_CR12","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S2468-1253(20)30090-X","volume":"5","author":"M Eslam","year":"2020","unstructured":"Eslam, M., Fan, J.-G. & Mendez-Sanchez, N. Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health. Lancet Gastroenterol. Hepatol. 5, 713\u2013715 (2020).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"1318_CR13","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.1038\/s41596-021-00519-z","volume":"16","author":"C Everett","year":"2021","unstructured":"Everett, C. et al. Overview of the Microbiome Among Nurses study (Micro-N) as an example of prospective characterization of the microbiome within cohort studies. Nat. Protoc. 16, 2724\u20132731 (2021).","journal-title":"Nat. Protoc."},{"key":"1318_CR14","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2105\/AJPH.2016.303338","volume":"106","author":"Y Bao","year":"2016","unstructured":"Bao, Y. et al. Origin, methods, and evolution of the Three Nurses\u2019 Health Studies. Am. J. Public Health 106, 1573\u20131581 (2016).","journal-title":"Am. J. Public Health"},{"key":"1318_CR15","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/s41587-023-01688-w","volume":"41","author":"A Blanco-M\u00edguez","year":"2023","unstructured":"Blanco-M\u00edguez, A. et al. Extending and improving metagenomic taxonomic profiling with uncharacterized species using MetaPhlAn 4. Nat. Biotechnol. 41, 1633\u20131644 (2023).","journal-title":"Nat. Biotechnol."},{"key":"1318_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655\u2013662 (2019).","journal-title":"Nature"},{"key":"1318_CR17","doi-asserted-by":"publisher","first-page":"740636","DOI":"10.3389\/fphar.2021.740636","volume":"12","author":"TU Maioli","year":"2021","unstructured":"Maioli, T. U. et al. Possible benefits of Faecalibacterium prausnitzii for obesity-associated gut disorders. Front. Pharmacol. 12, 740636 (2021).","journal-title":"Front. Pharmacol."},{"key":"1318_CR18","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.cmet.2020.06.005","volume":"32","author":"TG Oh","year":"2020","unstructured":"Oh, T. G. et al. A universal gut-microbiome-derived signature predicts cirrhosis. Cell Metab. 32, 878\u2013888.e876 (2020).","journal-title":"Cell Metab."},{"key":"1318_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12944-021-01440-w","volume":"20","author":"F Li","year":"2021","unstructured":"Li, F., Ye, J., Shao, C. & Zhong, B. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis. Lipids Health Dis. 20, 22 (2021).","journal-title":"Lipids Health Dis."},{"key":"1318_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature23889","volume":"550","author":"J Lloyd-Price","year":"2017","unstructured":"Lloyd-Price, J. et al. Strains, functions and dynamics in the expanded Human Microbiome Project. Nature 550, 61\u201366 (2017).","journal-title":"Nature"},{"key":"1318_CR21","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.3748\/wjg.v25.i22.2706","volume":"25","author":"G Bruno","year":"2019","unstructured":"Bruno, G. et al. Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified. World J. Gastroenterol. 25, 2706\u20132719 (2019).","journal-title":"World J. Gastroenterol."},{"key":"1318_CR22","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1053\/j.gastro.2024.03.026","volume":"167","author":"H Kim","year":"2024","unstructured":"Kim, H., Nzabarushimana, E., Huttenhower, C., Chan, A. T. & Nguyen, L. H. Altered microbial transcription in long-term proton pump inhibitor use: findings from a United States cohort study. Gastroenterology 167, 405\u2013408.e3 (2024).","journal-title":"Gastroenterology"},{"key":"1318_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03147-6","volume":"9","author":"M Tsukasaki","year":"2018","unstructured":"Tsukasaki, M. et al. Host defense against oral microbiota by bone-damaging T cells. Nat. Commun. 9, 701 (2018).","journal-title":"Nat. Commun."},{"key":"1318_CR24","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/hep.30908","volume":"71","author":"F Chen","year":"2020","unstructured":"Chen, F. et al. Lean NAFLD: a distinct entity shaped by differential metabolic adaptation. Hepatology 71, 1213\u20131227 (2020).","journal-title":"Hepatology"},{"key":"1318_CR25","doi-asserted-by":"publisher","first-page":"eabn4722","DOI":"10.1126\/scitranslmed.abn4722","volume":"15","author":"KN Thompson","year":"2023","unstructured":"Thompson, K. N. et al. Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes. Sci. Transl. Med. 15, eabn4722 (2023).","journal-title":"Sci. Transl. Med."},{"key":"1318_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1476-511X-13-69","volume":"13","author":"I Voloshin","year":"2014","unstructured":"Voloshin, I., Hahn-Obercyger, M., Anavi, S. & Tirosh, O. L-arginine conjugates of bile acids-a possible treatment for non-alcoholic fatty liver disease. Lipids Health Dis. 13, 69 (2014).","journal-title":"Lipids Health Dis."},{"key":"1318_CR27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40265-018-1020-5","volume":"79","author":"A Canbay","year":"2019","unstructured":"Canbay, A. & Sowa, J.-P. L-Ornithine L-aspartate (LOLA) as a novel approach for therapy of non-alcoholic fatty liver disease. Drugs 79, 39\u201344 (2019).","journal-title":"Drugs"},{"key":"1318_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1248\/bpb.29.234","volume":"29","author":"T Maeda","year":"2006","unstructured":"Maeda, T. et al. Role of polyamines derived from arginine in differentiation and proliferation of human blood cells. Biol. Pharm. Bull. 29, 234\u2013239 (2006).","journal-title":"Biol. Pharm. Bull."},{"key":"1318_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3390\/biom12040501","volume":"12","author":"J Rieck","year":"2022","unstructured":"Rieck, J., Skatchkov, S. N., Derst, C., Eaton, M. J. & Veh, R. W. Unique chemistry, intake, and metabolism of polyamines in the central nervous system (CNS) and its body. Biomolecules 12, 501 (2022).","journal-title":"Biomolecules"},{"key":"1318_CR30","doi-asserted-by":"publisher","first-page":"i34","DOI":"10.1093\/bioinformatics\/btab327","volume":"37","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Thompson, K. N., Huttenhower, C. & Franzosa, E. A. Statistical approaches for differential expression analysis in metatranscriptomics. Bioinformatics 37, i34\u2013i41 (2021).","journal-title":"Bioinformatics"},{"key":"1318_CR31","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1002\/hep4.1944","volume":"6","author":"T Testerman","year":"2022","unstructured":"Testerman, T., Li, Z., Galuppo, B., Graf, J. & Santoro, N. Insights from shotgun metagenomics into bacterial species and metabolic pathways associated with NAFLD in obese youth. Hepatol. Commun. 6, 1962\u20131974 (2022).","journal-title":"Hepatol. Commun."},{"key":"1318_CR32","doi-asserted-by":"publisher","first-page":"811399","DOI":"10.3389\/fmolb.2021.811399","volume":"8","author":"Y Xiong","year":"2021","unstructured":"Xiong, Y. et al. Dynamic alterations of the gut microbial pyrimidine and purine metabolism in the development of liver cirrhosis. Front. Mol. Biosci. 8, 811399 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"1318_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41564-018-0306-4","volume":"4","author":"EA Franzosa","year":"2019","unstructured":"Franzosa, E. A. et al. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat. Microbiol 4, 293\u2013305 (2019).","journal-title":"Nat. Microbiol"},{"key":"1318_CR34","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.chom.2021.07.013","volume":"29","author":"W Li","year":"2021","unstructured":"Li, W. et al. A bacterial bile acid metabolite modulates Treg activity through the nuclear hormone receptor NR4A1. Cell Host Microbe 29, 1366\u20131377.e1369 (2021).","journal-title":"Cell Host Microbe"},{"key":"1318_CR35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41586-021-03832-5","volume":"599","author":"Y Sato","year":"2021","unstructured":"Sato, Y. et al. Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians. Nature 599, 458\u2013464 (2021).","journal-title":"Nature"},{"key":"1318_CR36","doi-asserted-by":"publisher","first-page":"e0151829","DOI":"10.1371\/journal.pone.0151829","volume":"11","author":"M Mouzaki","year":"2016","unstructured":"Mouzaki, M. et al. Bile acids and dysbiosis in non-alcoholic fatty liver disease. PLoS ONE 11, e0151829 (2016).","journal-title":"PLoS ONE"},{"key":"1318_CR37","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1210\/jc.2011-0531","volume":"96","author":"P Codo\u00f1er-Franch","year":"2011","unstructured":"Codo\u00f1er-Franch, P., Tav\u00e1rez-Alonso, S., Murria-Estal, R., Herrera-Mart\u00edn, G. & Alonso-Iglesias, E. Polyamines are increased in obese children and are related to markers of oxidative\/nitrosative stress and angiogenesis. J. Clin. Endocrinol. Metab. 96, 2821\u20132825 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1318_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47216-2","volume":"9","author":"K Enooku","year":"2019","unstructured":"Enooku, K. et al. Altered serum acylcarnitine profile is associated with the status of nonalcoholic fatty liver disease (NAFLD) and NAFLD-related hepatocellular carcinoma. Sci. Rep. 9, 10663 (2019).","journal-title":"Sci. Rep."},{"key":"1318_CR39","first-page":"7433","volume":"24","author":"Y Chang","year":"2020","unstructured":"Chang, Y. et al. A targeted metabolomic profiling of plasma acylcarnitines in nonalcoholic fatty liver disease. Eur. Rev. Med. Pharm. Sci. 24, 7433\u20137441 (2020).","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"1318_CR40","doi-asserted-by":"publisher","first-page":"E1378","DOI":"10.1152\/ajpendo.00656.2013","volume":"306","author":"JM Rutkowsky","year":"2014","unstructured":"Rutkowsky, J. M. et al. Acylcarnitines activate proinflammatory signaling pathways. Am. J. Physiol. Endocrinol. Metab. 306, E1378\u2013E1387 (2014).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1318_CR41","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1136\/gutjnl-2017-315193","volume":"67","author":"N Fujiwara","year":"2018","unstructured":"Fujiwara, N. et al. CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity. Gut 67, 1493\u20131504 (2018).","journal-title":"Gut"},{"key":"1318_CR42","doi-asserted-by":"publisher","first-page":"i378","DOI":"10.1093\/bioinformatics\/btac232","volume":"38","author":"AR Ghazi","year":"2022","unstructured":"Ghazi, A. R. et al. High-sensitivity pattern discovery in large, paired multiomic datasets. Bioinformatics 38, i378\u2013i385 (2022).","journal-title":"Bioinformatics"},{"key":"1318_CR43","first-page":"1353881","volume":"28","author":"B Pugin","year":"2017","unstructured":"Pugin, B. et al. A wide diversity of bacteria from the human gut produces and degrades biogenic amines. Microb. Ecol. Health Dis. 28, 1353881 (2017).","journal-title":"Microb. Ecol. Health Dis."},{"key":"1318_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s41479-021-00082-x","volume":"13","author":"B Nanduri","year":"2021","unstructured":"Nanduri, B. & Swiatlo, E. The expansive effects of polyamines on the metabolism and virulence of Streptococcus pneumoniae. Pneumonia 13, 4 (2021).","journal-title":"Pneumonia"},{"key":"1318_CR45","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s00726-017-2447-9","volume":"49","author":"T Hussain","year":"2017","unstructured":"Hussain, T. et al. Polyamines: therapeutic perspectives in oxidative stress and inflammatory diseases. Amino Acids 49, 1457\u20131468 (2017).","journal-title":"Amino Acids"},{"key":"1318_CR46","first-page":"71","volume":"8","author":"JC Fernandez-Garcia","year":"2019","unstructured":"Fernandez-Garcia, J. C. et al. Type 2 diabetes is associated with a different pattern of serum polyamines: a case-control study from the PREDIMED-plus trial. J. Clin. Med. Res. 8, 71 (2019).","journal-title":"J. Clin. Med. Res."},{"key":"1318_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/00007691-200104000-00001","volume":"23","author":"M Oellerich","year":"2001","unstructured":"Oellerich, M. & Armstrong, V. W. The MEGX test: a tool for the real-time assessment of hepatic function. Ther. Drug Monit. 23, 81\u201392 (2001).","journal-title":"Ther. Drug Monit."},{"key":"1318_CR48","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1053\/j.gastro.2020.07.005","volume":"159","author":"S Lang","year":"2020","unstructured":"Lang, S. et al. Intestinal virome signature associated with severity of nonalcoholic fatty liver disease. Gastroenterology 159, 1839\u20131852 (2020).","journal-title":"Gastroenterology"},{"key":"1318_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45794-y","volume":"15","author":"Z Cao","year":"2024","unstructured":"Cao, Z. et al. The gut ileal mucosal virome is disturbed in patients with Crohn\u2019s disease and exacerbates intestinal inflammation in mice. Nat. Commun. 15, 1638 (2024).","journal-title":"Nat. Commun."},{"key":"1318_CR50","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1053\/j.gastro.2018.04.018","volume":"155","author":"G Nakatsu","year":"2018","unstructured":"Nakatsu, G. et al. Alterations in enteric virome are associated with colorectal cancer and survival outcomes. Gastroenterology 155, 529\u2013541.e525 (2018).","journal-title":"Gastroenterology"},{"key":"1318_CR51","doi-asserted-by":"publisher","first-page":"e10041","DOI":"10.1371\/journal.pone.0010041","volume":"5","author":"P Colson","year":"2010","unstructured":"Colson, P. et al. Pepper mild mottle virus, a plant virus associated with specific immune responses, fever, abdominal pains, and pruritus in humans. PLoS ONE 5, e10041 (2010).","journal-title":"PLoS ONE"},{"key":"1318_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5498","volume":"5","author":"BE Dutilh","year":"2014","unstructured":"Dutilh, B. E. et al. A highly abundant bacteriophage discovered in the unknown sequences of human faecal metagenomes. Nat. Commun. 5, 4498 (2014).","journal-title":"Nat. Commun."},{"key":"1318_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-020-00867-0","volume":"8","author":"K Kieft","year":"2020","unstructured":"Kieft, K., Zhou, Z. & Anantharaman, K. VIBRANT: automated recovery, annotation and curation of microbial viruses, and evaluation of viral community function from genomic sequences. Microbiome 8, 90 (2020).","journal-title":"Microbiome"},{"key":"1318_CR54","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S1570-0232(03)00609-3","volume":"797","author":"RA Moxley","year":"2003","unstructured":"Moxley, R. A., Jarrett, H. W. & Mitra, S. Methods for transcription factor separation. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 797, 269\u2013288 (2003).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"1318_CR55","doi-asserted-by":"publisher","first-page":"e3002083","DOI":"10.1371\/journal.pbio.3002083","volume":"21","author":"S Roux","year":"2023","unstructured":"Roux, S. et al. iPHoP: an integrated machine learning framework to maximize host prediction for metagenome-derived viruses of archaea and bacteria. PLoS Biol. 21, e3002083 (2023).","journal-title":"PLoS Biol."},{"key":"1318_CR56","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s43705-022-00182-9","volume":"2","author":"R Hern\u00e1ndez Medina","year":"2022","unstructured":"Hern\u00e1ndez Medina, R. et al. Machine learning and deep learning applications in microbiome research. ISME Commun. 2, 98 (2022).","journal-title":"ISME Commun."},{"key":"1318_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/2049-2618-1-11","volume":"1","author":"A Statnikov","year":"2013","unstructured":"Statnikov, A. et al. A comprehensive evaluation of multicategory classification methods for microbiomic data. Microbiome 1, 11 (2013).","journal-title":"Microbiome"},{"key":"1318_CR58","doi-asserted-by":"publisher","first-page":"e1004977","DOI":"10.1371\/journal.pcbi.1004977","volume":"12","author":"E Pasolli","year":"2016","unstructured":"Pasolli, E., Truong, D. T., Malik, F., Waldron, L. & Segata, N. Machine learning meta-analysis of large metagenomic datasets: tools and biological insights. PLoS Comput. Biol. 12, e1004977 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"1318_CR59","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/acr.24180","volume":"72","author":"JD FitzGerald","year":"2020","unstructured":"FitzGerald, J. D. et al. 2020 American College of Rheumatology Guideline for the Management of Gout. Arthritis Care Res. 72, 744\u2013760 (2020).","journal-title":"Arthritis Care Res."},{"key":"1318_CR60","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1038\/4441022a","volume":"444","author":"RE Ley","year":"2006","unstructured":"Ley, R. E., Turnbaugh, P. J., Klein, S. & Gordon, J. I. Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022\u20131023 (2006).","journal-title":"Nature"},{"key":"1318_CR61","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/s41586-022-04648-7","volume":"606","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Discovery of bioactive microbial gene products in inflammatory bowel disease. Nature 606, 754\u2013760 (2022).","journal-title":"Nature"},{"key":"1318_CR62","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s44320-024-00027-8","volume":"20","author":"A Bhosle","year":"2024","unstructured":"Bhosle, A. et al. Integrated annotation prioritizes metabolites with bioactivity in inflammatory bowel disease. Mol. Syst. Biol. 20, 338\u2013361 (2024).","journal-title":"Mol. Syst. Biol."},{"key":"1318_CR63","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.cell.2018.09.055","volume":"175","author":"A Koh","year":"2018","unstructured":"Koh, A. et al. Microbially produced imidazole propionate impairs insulin signaling through mTORC1. Cell 175, 947\u2013961.e917 (2018).","journal-title":"Cell"},{"key":"1318_CR64","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/eurheartj\/ehab644","volume":"43","author":"A Haghikia","year":"2022","unstructured":"Haghikia, A. et al. Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism. Eur. Heart J. 43, 518\u2013533 (2022).","journal-title":"Eur. Heart J."},{"key":"1318_CR65","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/s41591-022-02016-6","volume":"28","author":"AS Meijnikman","year":"2022","unstructured":"Meijnikman, A. S. et al. Microbiome-derived ethanol in nonalcoholic fatty liver disease. Nat. Med. 28, 2100\u20132106 (2022).","journal-title":"Nat. Med."},{"key":"1318_CR66","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.femsre.2004.09.003","volume":"29","author":"M Begley","year":"2005","unstructured":"Begley, M., Gahan, C. G. M. & Hill, C. The interaction between bacteria and bile. FEMS Microbiol. Rev. 29, 625\u2013651 (2005).","journal-title":"FEMS Microbiol. Rev."},{"key":"1318_CR67","doi-asserted-by":"publisher","first-page":"eabm3135","DOI":"10.1126\/scisignal.abm3135","volume":"14","author":"AM VanHook","year":"2021","unstructured":"VanHook, A. M. Bile acids for immune tolerance. Sci. Signal. 14, eabm3135 (2021).","journal-title":"Sci. Signal."},{"key":"1318_CR68","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","volume":"576","author":"S Hang","year":"2019","unstructured":"Hang, S. et al. Bile acid metabolites control TH17 and Treg cell differentiation. Nature 576, 143\u2013148 (2019).","journal-title":"Nature"},{"key":"1318_CR69","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5114\/ceh.2017.68466","volume":"3","author":"M \u015awiderska","year":"2017","unstructured":"\u015awiderska, M. et al. The interplay between Th17 and T-regulatory responses as well as adipokines in the progression of non-alcoholic fatty liver disease. Clin. Exp. Hepatol. 3, 127\u2013134 (2017).","journal-title":"Clin. Exp. Hepatol."},{"key":"1318_CR70","doi-asserted-by":"publisher","first-page":"352","DOI":"10.2174\/1573399812666160217122530","volume":"13","author":"J Sarparanta","year":"2017","unstructured":"Sarparanta, J., Garc\u00eda-Macia, M. & Singh, R. Autophagy and mitochondria in obesity and type 2 diabetes. Curr. Diabetes Rev. 13, 352\u2013369 (2017).","journal-title":"Curr. Diabetes Rev."},{"key":"1318_CR71","doi-asserted-by":"publisher","first-page":"33588","DOI":"10.1074\/jbc.M507621200","volume":"280","author":"TR Koves","year":"2005","unstructured":"Koves, T. R. et al. Peroxisome proliferator-activated receptor-\u03b3 co-activator 1alpha-mediated metabolic remodeling of skeletal myocytes mimics exercise training and reverses lipid-induced mitochondrial inefficiency. J. Biol. Chem. 280, 33588\u201333598 (2005).","journal-title":"J. Biol. Chem."},{"key":"1318_CR72","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cmet.2007.10.013","volume":"7","author":"TR Koves","year":"2008","unstructured":"Koves, T. R. et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metab. 7, 45\u201356 (2008).","journal-title":"Cell Metab."},{"key":"1318_CR73","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1038\/oby.2009.510","volume":"18","author":"SJ Mihalik","year":"2010","unstructured":"Mihalik, S. J. et al. Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity. Obesity 18, 1695\u20131700 (2010).","journal-title":"Obesity"},{"key":"1318_CR74","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-35861-1","volume":"14","author":"M Yang","year":"2023","unstructured":"Yang, M. et al. Western diet contributes to the pathogenesis of non-alcoholic steatohepatitis in male mice via remodeling gut microbiota and increasing production of 2-oleoylglycerol. Nat. Commun. 14, 228 (2023).","journal-title":"Nat. Commun."},{"key":"1318_CR75","doi-asserted-by":"publisher","first-page":"nzaa024","DOI":"10.1093\/cdn\/nzaa024","volume":"4","author":"S-Y Park","year":"2020","unstructured":"Park, S.-Y., Noureddin, M., Boushey, C., Wilkens, L. R. & Setiawan, V. W. Diet quality association with nonalcoholic fatty liver disease by cirrhosis status: the multiethnic cohort. Curr. Dev. Nutr. 4, nzaa024 (2020).","journal-title":"Curr. Dev. Nutr."},{"key":"1318_CR76","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.jcmgh.2023.09.005","volume":"17","author":"JMS Lemons","year":"2024","unstructured":"Lemons, J. M. S. et al. Enterobacteriaceae growth promotion by intestinal acylcarnitines, a biomarker of dysbiosis in inflammatory bowel disease. Cell Mol. Gastroenterol. Hepatol. 17, 131\u2013148 (2024).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1318_CR77","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.chom.2020.12.012","volume":"29","author":"C Tanes","year":"2021","unstructured":"Tanes, C. et al. Role of dietary fiber in the recovery of the human gut microbiome and its metabolome. Cell Host Microbe 29, 394\u2013407.e395 (2021).","journal-title":"Cell Host Microbe"},{"key":"1318_CR78","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth, R. A. et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576\u2013585 (2013).","journal-title":"Nat. Med."},{"key":"1318_CR79","doi-asserted-by":"publisher","first-page":"e2101498118","DOI":"10.1073\/pnas.2101498118","volume":"118","author":"LJ Rajakovich","year":"2021","unstructured":"Rajakovich, L. J., Fu, B., Bollenbach, M. & Balskus, E. P. Elucidation of an anaerobic pathway for metabolism of l-carnitine-derived \u03b3-butyrobetaine to trimethylamine in human gut bacteria. Proc. Natl Acad. Sci. USA 118, e2101498118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1318_CR80","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/bs.ampbs.2023.12.001","volume":"84","author":"SA Joyce","year":"2024","unstructured":"Joyce, S. A. & Clarke, D. J. Microbial metabolites as modulators of host physiology. Adv. Micro. Physiol. 84, 83\u2013133 (2024).","journal-title":"Adv. Micro. Physiol."},{"key":"1318_CR81","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1099\/mic.0.000080","volume":"161","author":"JA Meadows","year":"2015","unstructured":"Meadows, J. A. & Wargo, M. J. Carnitine in bacterial physiology and metabolism. Microbiology 161, 1161\u20131174 (2015).","journal-title":"Microbiology"},{"key":"1318_CR82","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1016\/j.jhep.2021.08.003","volume":"75","author":"CL Hsu","year":"2021","unstructured":"Hsu, C. L., Duan, Y., Fouts, D. E. & Schnabl, B. Intestinal virome and therapeutic potential of bacteriophages in liver disease. J. Hepatol. 75, 1465\u20131475 (2021).","journal-title":"J. Hepatol."},{"key":"1318_CR83","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.cell.2015.01.002","volume":"160","author":"JM Norman","year":"2015","unstructured":"Norman, J. M. et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell 160, 447\u2013460 (2015).","journal-title":"Cell"},{"key":"1318_CR84","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1038\/s41591-019-0667-0","volume":"25","author":"K Vehik","year":"2019","unstructured":"Vehik, K. et al. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat. Med. 25, 1865\u20131872 (2019).","journal-title":"Nat. Med."},{"key":"1318_CR85","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1136\/gutjnl-2020-322470","volume":"70","author":"JS Bajaj","year":"2021","unstructured":"Bajaj, J. S. et al. Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy. Gut 70, 1162\u20131173 (2021).","journal-title":"Gut"},{"key":"1318_CR86","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","volume":"17","author":"J Aron-Wisnewsky","year":"2020","unstructured":"Aron-Wisnewsky, J. et al. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders. Nat. Rev. Gastroenterol. Hepatol. 17, 279\u2013297 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1318_CR87","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.cmet.2017.04.001","volume":"25","author":"R Loomba","year":"2017","unstructured":"Loomba, R. et al. Gut microbiome-based metagenomic signature for non-invasive detection of advanced fibrosis in human nonalcoholic fatty liver disease. Cell Metab. 25, 1054\u20131062.e1055 (2017).","journal-title":"Cell Metab."},{"key":"1318_CR88","doi-asserted-by":"publisher","first-page":"154398","DOI":"10.1016\/j.metabol.2020.154398","volume":"113","author":"MN Kim","year":"2020","unstructured":"Kim, M. N. et al. Weight gain during early adulthood, trajectory of body shape and the risk of nonalcoholic fatty liver disease: a prospective cohort study among women. Metabolism 113, 154398 (2020).","journal-title":"Metabolism"},{"key":"1318_CR89","doi-asserted-by":"publisher","first-page":"E2329","DOI":"10.1073\/pnas.1319284111","volume":"111","author":"EA Franzosa","year":"2014","unstructured":"Franzosa, E. A. et al. Relating the metatranscriptome and metagenome of the human gut. Proc. Natl Acad. Sci. USA 111, E2329\u2013E2338 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1318_CR90","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/nbt.3935","volume":"35","author":"C Quince","year":"2017","unstructured":"Quince, C., Walker, A. W., Simpson, J. T., Loman, N. J. & Segata, N. Shotgun metagenomics, from sampling to analysis. Nat. Biotechnol. 35, 833\u2013844 (2017).","journal-title":"Nat. Biotechnol."},{"key":"1318_CR91","doi-asserted-by":"publisher","first-page":"e65088","DOI":"10.7554\/eLife.65088","volume":"10","author":"F Beghini","year":"2021","unstructured":"Beghini, F. et al. Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3. eLife 10, e65088 (2021).","journal-title":"eLife"},{"key":"1318_CR92","doi-asserted-by":"publisher","first-page":"D445","DOI":"10.1093\/nar\/gkz862","volume":"48","author":"R Caspi","year":"2020","unstructured":"Caspi, R. et al. The MetaCyc database of metabolic pathways and enzymes - a 2019 update. Nucleic Acids Res. 48, D445\u2013D453 (2020).","journal-title":"Nucleic Acids Res."},{"key":"1318_CR93","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nmeth.3313","volume":"12","author":"AA Shishkin","year":"2015","unstructured":"Shishkin, A. A. et al. Simultaneous generation of many RNA-seq libraries in a single reaction. Nat. Methods 12, 323\u2013325 (2015).","journal-title":"Nat. Methods"},{"key":"1318_CR94","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/s41591-019-0650-9","volume":"25","author":"RP Bhattacharyya","year":"2019","unstructured":"Bhattacharyya, R. P. et al. Simultaneous detection of genotype and phenotype enables rapid and accurate antibiotic susceptibility determination. Nat. Med. 25, 1858\u20131864 (2019).","journal-title":"Nat. Med."},{"key":"1318_CR95","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013D596 (2013).","journal-title":"Nucleic Acids Res."},{"key":"1318_CR96","unstructured":"Oksanen, J. et al. The vegan package: community ecology package (2007)."},{"key":"1318_CR97","doi-asserted-by":"publisher","first-page":"e1009442","DOI":"10.1371\/journal.pcbi.1009442","volume":"17","author":"H Mallick","year":"2021","unstructured":"Mallick, H. et al. Multivariable association discovery in population-scale meta-omics studies. PLoS Comput. Biol. 17, e1009442 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"1318_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02306-1","volume":"22","author":"J Wirbel","year":"2021","unstructured":"Wirbel, J. et al. Microbiome meta-analysis and cross-disease comparison enabled by the SIAMCAT machine learning toolbox. Genome Biol. 22, 93 (2021).","journal-title":"Genome Biol."},{"key":"1318_CR99","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nmeth.4468","volume":"14","author":"E Pasolli","year":"2017","unstructured":"Pasolli, E. et al. Accessible, curated metagenomic data through ExperimentHub. Nat. Methods 14, 1023\u20131024 (2017).","journal-title":"Nat. Methods"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01318-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01318-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01318-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T23:57:25Z","timestamp":1757203045000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01318-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":99,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["1318"],"URL":"https:\/\/doi.org\/10.1038\/s42255-025-01318-6","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.N. and B.H. were employees of Empress Therapeutics. C.H. is on the Scientific Advisory Board of Empress Therapeutics, Seres Therapeutics and ZOE Nutrition. All others declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}